TV3 fined over Herceptin story coverage

TV3's current affairs show 60 minutes has been ordered to pay the Government $3000 and run a correction after running an "unbalanced and inaccurate" story about breast cancer drug Herceptin.

Government drug funding agency Pharmac complained to the Broadcasting Standards Authority after 60 Minutes aired the story, examining breast cancer treatment in Australia and New Zealand, and the funding of the drug Herceptin, in October last year.

Herceptin is publicly funded in Australia but funded here only for women with advanced breast cancer.